Published in J Clin Invest on May 01, 1992
The human cumulus--oocyte complex gene-expression profile. Hum Reprod (2006) 1.60
Activin promotes follicular integrity and oogenesis in cultured pre-antral bovine follicles. Mol Hum Reprod (2010) 0.90
Activin A inhibits activation of human primordial follicles in vitro. J Assist Reprod Genet (2010) 0.80
A Simplified Method for Three-Dimensional (3-D) Ovarian Tissue Culture Yielding Oocytes Competent to Produce Full-Term Offspring in Mice. PLoS One (2015) 0.76
The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. J Immunol (1990) 1.83
Inhibin A-subunit cDNAs from porcine ovary and human placenta. Proc Natl Acad Sci U S A (1986) 1.16
Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res (1988) 1.14
Dynamic changes in inhibin messenger RNAs in rat ovarian follicles during the reproductive cycle. Science (1988) 1.06
Intragonadal regulation of follicular maturation. Endocr Rev (1989) 1.02
Activin-A, inhibin and transforming growth factor-beta modulate growth of two gonadal cell lines. Endocrinology (1989) 0.98
Inhibin and activin locally regulate rat ovarian folliculogenesis. Endocrinology (1990) 0.96
Inhibin and beta type transforming growth factor (TGF beta) have opposite modulating effects on the follicle stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells. Biochem Biophys Res Commun (1986) 0.92
Rapid changes in the expression of inhibin alpha-, beta A-, and beta B-subunits in ovarian cell types during the rat estrous cycle. Mol Endocrinol (1988) 0.89
Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads. Endocr Rev (1990) 0.88
Erythroid differentiation factor can modulate follicular granulosa cell functions. Biochem Biophys Res Commun (1988) 0.86
The effect of bovine activin and follicle-stimulating hormone (FSH) suppressing protein/follistatin on FSH-induced differentiation of rat granulosa cells in vitro. Mol Cell Endocrinol (1990) 0.86
Localization of inhibin/activin subunit mRNAs within the primate ovary. Mol Endocrinol (1990) 0.86
Recombinant human activin-A promotes proliferation of human luteinized preovulatory granulosa cells in vitro. J Clin Endocrinol Metab (1990) 0.85
Effects of bovine inhibin, transforming growth factor-beta and bovine Activin-A on granulosa cell differentiation. Biochem Biophys Res Commun (1987) 0.85
Inhibin A-subunit gene expression in the ovaries of immature female rats is stimulated by pregnant mare serum gonadotrophin. Biochem Biophys Res Commun (1986) 0.84
Human recombinant activin-A inhibits proliferation of human fetal adrenal cells in vitro. J Clin Endocrinol Metab (1990) 0.83
Identification of a specific receptor for erythroid differentiation factor on follicular granulosa cell. J Biol Chem (1988) 0.82
Recombinant expression and characterization of human activin A. Mol Endocrinol (1988) 0.82
Activin stimulation of inhibin secretion and messenger RNA levels in cultured granulosa cells. Mol Endocrinol (1989) 0.80
Induction of follicle stimulating hormone receptor by erythroid differentiation factor on rat granulosa cell. Biochem Biophys Res Commun (1988) 0.79
Effects of oestradiol and prolactin on progesterone production by rhesus monkey luteal cells in vitro. Acta Endocrinol (Copenh) (1985) 0.78
Changes in serum concentrations of inhibin in cyclic pigs. J Endocrinol (1988) 0.78
Inhibin mRNAs in ovine and bovine ovarian follicles and corpora lutea throughout the estrous cycle and gestation. Mol Cell Endocrinol (1989) 0.78
Inhibin as an oocyte meiotic inhibitor. Mol Cell Endocrinol (1989) 0.78
Activin-A inhibits oxytocin and progesterone production by preovulatory bovine granulosa cells in vitro. Endocrinology (1990) 0.78
Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle. J Clin Endocrinol Metab (1991) 0.78
Cellular localization of inhibin mRNA in the bovine ovary by in-situ hybridization. J Reprod Fertil (1989) 0.77
Inhibin secretion by the sheep ovary during the luteal and follicular phases of the oestrous cycle and following stimulation with FSH. J Endocrinol (1988) 0.77
Gonadotropic stimulation of inhibin secretion by the human ovary during the follicular and early luteal phase of the cycle. J Clin Endocrinol Metab (1988) 0.77
Inhibin concentration in the culture media of human oocyte-cumulus-corona cell complexes is not related to subsequent embryo cleavage. Fertil Steril (1986) 0.77
Inhibition of follicular development by a potent antagonistic analog of gonadotropin-releasing hormone (detirelix). J Clin Endocrinol Metab (1991) 0.77
Differential expression of inhibin alpha and beta A subunit genes in rat and mouse ovarian follicles during pregnancy. J Mol Endocrinol (1990) 0.77
Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron (1990) 4.15
Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J Natl Cancer Inst (2001) 2.27
In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). Clin Cancer Res (2000) 2.08
Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev (1997) 2.00
African Americans and high blood pressure: the role of stereotype threat. Psychol Sci (2001) 1.97
Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am J Pathol (1998) 1.90
Comparison of angioplasty and surgery for unoperated coarctation of the aorta. Circulation (1993) 1.88
Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br J Cancer (2010) 1.85
Massive edema of the ovary simulating fibroma. Obstet Gynecol (1969) 1.71
Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Ann N Y Acad Sci (2000) 1.67
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation (1998) 1.65
Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab (1996) 1.64
Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol (2001) 1.64
Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles. J Clin Endocrinol Metab (1998) 1.54
Expression of interleukin-1beta in human breast carcinoma. Cancer (1997) 1.52
Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ (2004) 1.44
Decreased spinal mineral content in amenorrheic women. JAMA (1984) 1.43
Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus. J Clin Endocrinol Metab (1997) 1.39
Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res (1999) 1.39
Coronary arterial-right heart fistulae. Long-term observations in seven patients. Circulation (1973) 1.37
Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat Med (2000) 1.32
Vulval schistosomiasis. J R Soc Med (1993) 1.30
In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J Clin Endocrinol Metab (1994) 1.28
Induction of vascular endothelial growth factor and hypoxia-inducible factor-1alpha by global ischemia in rat brain. Neuroscience (2000) 1.26
Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. J Lipid Res (2000) 1.23
Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues. J Clin Endocrinol Metab (1998) 1.22
Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms. Radiology (1986) 1.21
Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril (2000) 1.21
Regulation of human gonadotropins. XII. Increase in serum gonadotropins in response to estradiol. J Clin Endocrinol Metab (1972) 1.12
Induction of vascular endothelial growth factor receptors and phosphatidylinositol 3'-kinase/Akt signaling by global cerebral ischemia in the rat. Neuroscience (2000) 1.12
Regulation of human gonadotropins. X. Episodic fluctuation of LH during the menstrual cycle. J Clin Endocrinol Metab (1971) 1.11
Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling. J Biol Chem (2001) 1.10
The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers. J Pediatr (1979) 1.09
Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab (1998) 1.09
Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology (1998) 1.09
Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Mol Hum Reprod (1999) 1.08
Acquired subvalvular right ventricular outflow obstruction in patients with ventricular septal defect. Am J Med (1972) 1.07
Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab (1996) 1.07
Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea. Invest Ophthalmol Vis Sci (1996) 1.06
Secondary amenorrhea, infertility and hirsutism. Postgrad Med (1969) 1.06
Septic pulmonary emboli. Radiology (1970) 1.04
Bone-inducing activity of mature BMP-2b produced from a hybrid BMP-2a/2b precursor. Mol Endocrinol (1991) 1.03
CB1 cannabinoid receptor induction in experimental stroke. Ann Neurol (2000) 1.03
Self-image resilience and dissonance: the role of affirmational resources. J Pers Soc Psychol (1993) 1.02
Compensatory conviction in the face of personal uncertainty: going to extremes and being oneself. J Pers Soc Psychol (2001) 1.00
Mechanisms of lysolipid phosphate effects on cellular survival and proliferation. Ann N Y Acad Sci (2000) 1.00
Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin). Fertil Steril (1985) 0.98
Prebeta-1 HDL in plasma of normolipidemic individuals: influences of plasma lipoproteins, age, and gender. J Lipid Res (1998) 0.97
HCG binding and stimulation of testosterone biosynthesis in the human fetal testis. J Clin Endocrinol Metab (1977) 0.97
Fluoroscopic removal of ingested alkaline batteries. Radiology (1984) 0.97
Regulation of production of activin A in human marrow stromal cells and monocytes. Exp Hematol (1992) 0.96
Disturbances of the transitional circulation: spectrum of pulmonary hypertension and myocardial dysfunction. J Pediatr (1976) 0.96
Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome. Hum Reprod (2001) 0.95
Current status of human gonadotropin radioimmunoassay. Obstet Gynecol Surv (1969) 0.94
Modulation of pituitary gonadotropin response to gonadotropin-releasing hormone by estradiol. J Clin Endocrinol Metab (1974) 0.94
A decline in myometrial nitric oxide synthase expression is associated with labor and delivery. J Clin Invest (1997) 0.94
Altered expression of the neuropeptide-processing enzyme carboxypeptidase E in the rat brain after global ischemia. J Cereb Blood Flow Metab (2001) 0.94
Proliferation and apoptosis in the human adrenal cortex during the fetal and perinatal periods: implications for growth and remodeling. J Clin Endocrinol Metab (1999) 0.94
Radioimmunoassayable serum LH and FSH in girls with sexual precocity, premature thelarche and adrenarche. J Clin Endocrinol Metab (1969) 0.94
Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma. Cell Growth Differ (1996) 0.94
Hormonal regulation of messenger ribonucleic acids for P450scc (cholesterol side-chain cleavage enzyme) and P450c17 (17 alpha-hydroxylase/17,20-lyase) in cultured human fetal adrenal cells. J Clin Endocrinol Metab (1987) 0.93
Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. J Clin Endocrinol Metab (1993) 0.93
Progesterone effects on gonadotropin release in women pretreated with estradiol. J Clin Endocrinol Metab (1978) 0.93
Fixation, fine structure, and immunostaining for neuropeptides: perfusion versus immersion of the neuroendocrine hypothalamus. J Histochem Cytochem (1986) 0.93
Localization of cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17 alpha-hydroxylase/17, 20-lyase, and 3 beta-hydroxysteroid dehydrogenase isomerase steroidogenic enzymes in human and rhesus monkey fetal adrenal glands: reappraisal of functional zonation. J Clin Endocrinol Metab (1993) 0.93
Infundibular gonadotropin-releasing hormone neurons are inhibited by direct opioid and autoregulatory synapses in juvenile monkeys. Neuroendocrinology (1988) 0.92
Combined mitral and aortic regurgitation in ankylosing spondylitis. Angiographic and anatomic features. Am J Med (1974) 0.92
Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells. J Clin Endocrinol Metab (1998) 0.92
MRSA colonisation and subsequent risk of infection despite effective eradication in orthopaedic elective surgery. J Bone Joint Surg Br (2011) 0.91
Androgens and masculinization of genitalia in the spotted hyaena (Crocuta crocuta). 1. Urogenital morphology and placental androgen production during fetal life. J Reprod Fertil (1998) 0.91
Expression and coupling characteristics of the CRH and orexin type 2 receptors in human fetal adrenals. J Clin Endocrinol Metab (2001) 0.91
Ultrastructural localization of luteinizing hormone-releasing hormone in the median eminence of the rat. Brain Res (1975) 0.90
The genesis of cell types in the adenohypophysis of the human fetus as observed with immunocytochemistry. Am J Anat (1975) 0.90
Serum gonadotropin, testosterone and prolactin concentrations throughout puberty in boys: a longitudinal study. J Clin Endocrinol Metab (1974) 0.90
Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factor. Am J Obstet Gynecol (2000) 0.90
Corticotropin-releasing hormone-binding protein in primates. Am J Primatol (2001) 0.89
Quantitation of endogenous and exogenous gonadotropin releasing hormone by radioimmunoassay. J Clin Endocrinol Metab (1973) 0.89
Role of angiopoietins in reproductive tract angiogenesis. Obstet Gynecol Surv (2000) 0.89
Serum gonadotropins before, at the inception of, and following human pregnancy. J Clin Endocrinol Metab (1969) 0.89
Functional maturation of the primate fetal adrenal in vivo: I. Role of insulin-like growth factors (IGFs), IGF-I receptor, and IGF binding proteins in growth regulation. Endocrinology (1996) 0.88
Human prolactin: secretion, regulation and pathophysiology. Obstet Gynecol Surv (1973) 0.88
Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. I. Effects of varying duration of estradiol administration. J Clin Endocrinol Metab (1975) 0.88
Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea. Am J Obstet Gynecol (1977) 0.88
Systemic atrioventricular valve regurgitation in corrected transpositon of the great vessels. Angiographic differentiation of operable and nonoperable valve deformities. Am J Cardiol (1976) 0.88
A precursor form of vascular endothelial growth factor arises by initiation from an upstream in-frame CUG codon. Biochem J (2001) 0.88
Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. II. Effects of varying concentrations of estradiol. J Clin Endocrinol Metab (1976) 0.88
Human luteinizing hormone in serum during the menstrual cycle: determination by radioimmunoassay. J Clin Endocrinol Metab (1966) 0.88
Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads. Endocr Rev (1990) 0.88
Fine structure of Leydig cells from an arrhenoblastoma of the ovary. Am J Obstet Gynecol (1969) 0.87
Postnatal overfeeding leads to obesity and exacerbated febrile responses to lipopolysaccharide throughout life. J Neuroendocrinol (2012) 0.87
Angiogenesis in the human female reproductive tract. Obstet Gynecol Surv (1995) 0.87
Ultrastructural localization of somatostatin in pancreatic islets of the rat. Endocrinology (1975) 0.87
Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix). Fertil Steril (1995) 0.87
A radioimmunoassay for dehydroepiandrosterone sulfate in the circulation of rhesus monkeys. Steroids (1983) 0.86
Percutaneous nephrostomy for nonoperative management of fungal urinary tract infections. J Vasc Interv Radiol (1993) 0.86